{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:07:15Z","timestamp":1791360435407,"version":"4.3.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sleep disturbances elevate brain amyloid-beta (A\u03b2) levels and represent a modifiable risk factor for Alzheimer\u2019s disease (AD). The orexin\/hypocretin system regulates sleep\u2013wake behavior and has emerged as a therapeutic target in AD; however, the effects of FDA-approved dual orexin receptor antagonists (DORAs) on amyloid pathology remain unclear. We compared lemborexant, an FDA-approved DORA, to doxepin, an antihistaminergic sleep medication, on amyloid pathology and microglial responses in PSAPP mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PSAPP mice received lemborexant (10 or 30\u2009mg\/kg\/day), doxepin (35\u2009mg\/kg\/day), or vehicle for 6\u2009weeks beginning prior to plaque onset or 4\u2009weeks after established pathology. Sleep was assessed by piezoelectric monitoring and EEG\/EMG polysomnography. Amyloid pathology and microglial responses were quantified by immunohistochemistry, confocal microscopy, and single-cell RNA sequencing. Microglial depletion was induced with the CSF1R inhibitor PLX3397.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Lemborexant enhanced sleep quality with less active-phase sedation than doxepin. Both drugs reduced initial diffuse plaque deposition, but only lemborexant prevented fibrillar plaque accumulation in young mice and slowed plaque growth in older mice. Lemborexant increased peri-plaque microglial CD68 expression and enhanced A\u03b2 phagocytosis in vivo. Single-cell transcriptomics revealed a shift toward activated, DAM-like microglial states with upregulation of phagocytic genes without broad inflammatory induction. Microglial depletion abolished lemborexant\u2019s anti-amyloid effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Lemborexant mitigates amyloid pathology by augmenting microglial phagocytic function, positioning DORAs as promising therapeutics that couple sleep promotion with beneficial microglial modulation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-026-00948-y","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:13:43Z","timestamp":1779466423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dual orexin receptor antagonism with lemborexant enhances microglial clearance of \u03b2-amyloid in mice"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9998-9709","authenticated-orcid":false,"given":"Ashish","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Segawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohui","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoutang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley E.","family":"Irmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Constantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Kanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Colonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon L.","family":"Macauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn Y.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Moline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8873-0360","authenticated-orcid":false,"given":"Erik S.","family":"Musiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"948_CR1","doi-asserted-by":"publisher","unstructured":"Holtzman DM, Morris JC, Goate AM. Alzheimer\u2019s disease: the challenge of the second century. Sci Transl Med. 2011;3(77):sr771\u2013771. https:\/\/doi.org\/10.1126\/scitranslmed.3002369.","DOI":"10.1126\/scitranslmed.3002369"},{"issue":"5","key":"948_CR2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/jamaneurol.2013.2334","volume":"70","author":"YES Ju","year":"2013","unstructured":"Ju YES, McLeland JS, Toedebusch CD, Xiong C, Fagan AM, Duntley SP, et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurol. 2013;70(5):587\u201393. https:\/\/doi.org\/10.1001\/jamaneurol.2013.2334.","journal-title":"JAMA Neurol"},{"issue":"2","key":"948_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrneurol.2013.269","volume":"10","author":"YES Ju","year":"2014","unstructured":"Ju YES, Lucey BP, Holtzman DM. Sleep and Alzheimer disease pathology\u2014a bidirectional relationship. Nat Rev Neurol. 2014;10(2):115\u201319. https:\/\/doi.org\/10.1038\/nrneurol.2013.269.","journal-title":"Nat Rev Neurol"},{"issue":"5955","key":"948_CR4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1126\/science.1180962","volume":"326","author":"JE Kang","year":"2009","unstructured":"Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, et al. Amyloid-\u03b2 dynamics are regulated by orexin and the sleep-wake cycle. Science. 2009;326(5955):1005\u201307. https:\/\/doi.org\/10.1126\/science.1180962.","journal-title":"Science"},{"issue":"6429","key":"948_CR5","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1126\/science.aav2546","volume":"363","author":"JK Holth","year":"2019","unstructured":"Holth JK, Fritschi SK, Wang C, Pedersen NP, Cirrito JR, Mahan TE, et al. The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans. Science. 2019;363(6429):880\u201384. https:\/\/doi.org\/10.1126\/science.aav2546.","journal-title":"Science"},{"issue":"1","key":"948_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/ana.25117","volume":"83","author":"BP Lucey","year":"2018","unstructured":"Lucey BP, Hicks TJ, McLeland JS, Toedebusch CD, Boyd J, Elbert DL, et al. Effect of sleep on overnight cerebrospinal fluid amyloid \u03b2 kinetics. Ann Neurol. 2018;83(1):197\u2013204. https:\/\/doi.org\/10.1002\/ana.25117.","journal-title":"Ann Neurol"},{"key":"948_CR7","doi-asserted-by":"publisher","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med. 2012;4(147):ra147111\u2013147111. https:\/\/doi.org\/10.1126\/scitranslmed.3003748.","DOI":"10.1126\/scitranslmed.3003748"},{"issue":"49","key":"948_CR8","doi-asserted-by":"publisher","first-page":"16180","DOI":"10.1523\/JNEUROSCI.3020-14.2014","volume":"34","author":"JJ Iliff","year":"2014","unstructured":"Iliff JJ, Chen MJ, Plog BA, Zeppenfeld DM, Soltero M, Yang L, et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci. 2014;34(49):16180\u201393. https:\/\/doi.org\/10.1523\/JNEUROSCI.3020-14.2014. PubMed PMID: 25471560.","journal-title":"J Neurosci"},{"issue":"6156","key":"948_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1241224","volume":"342","author":"L Xie","year":"2013","unstructured":"Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373\u201377. https:\/\/doi.org\/10.1126\/science.1241224.","journal-title":"Science"},{"key":"948_CR10","doi-asserted-by":"publisher","unstructured":"Parhizkar S, Gent G, Chen Y, Rensing N, Gratuze M, Strout G, et al. Sleep deprivation exacerbates microglial reactivity and A\u03b2 deposition in a TREM2-dependent manner in mice. Sci Transl Med. 2023;15(693):eade6285. https:\/\/doi.org\/10.1126\/scitranslmed.ade6285.","DOI":"10.1126\/scitranslmed.ade6285"},{"key":"948_CR11","doi-asserted-by":"publisher","unstructured":"Wang C, Nambiar A, Strickland MR, Lee C, Parhizkar S, Moore AC, et al. APOE-\u03b54 synergizes with sleep disruption to accelerate A\u03b2 deposition and A\u03b2-associated tau seeding and spreading. J Clin Invest. 2023;133(14). https:\/\/doi.org\/10.1172\/JCI169131. PubMed PMID: 0.","DOI":"10.1172\/JCI169131"},{"issue":"1","key":"948_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1073\/pnas.95.1.322","volume":"95","author":"de Lecea L","year":"1998","unstructured":"de Lecea L, Kilduff TS, Peyron C, Gao XB, Foye PE, Danielson PE, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA. 1998;95(1):322\u201327. https:\/\/doi.org\/10.1073\/pnas.95.1.322.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"948_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/s0092-8674(00)81965-0","volume":"98","author":"L Lin","year":"1999","unstructured":"Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 1999;98(3):365\u201376. https:\/\/doi.org\/10.1016\/s0092-8674(00)81965-0. PubMed PMID: 10458611.","journal-title":"Cell"},{"issue":"4","key":"948_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","volume":"92","author":"T Sakurai","year":"1998","unstructured":"Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92(4):573\u201385. https:\/\/doi.org\/10.1016\/S0092-8674(00)80949-6.","journal-title":"Cell"},{"issue":"13","key":"948_CR15","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1084\/jem.20141788","volume":"211","author":"JH Roh","year":"2014","unstructured":"Roh JH, Jiang H, Finn MB, Stewart FR, Mahan TE, Cirrito JR, et al. Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer\u2019s disease. J Exp Med. 2014;211(13):2487\u201396. https:\/\/doi.org\/10.1084\/jem.20141788.","journal-title":"J Exp Med"},{"issue":"11","key":"948_CR16","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.5664\/jcsm.6800","volume":"13","author":"P Murphy","year":"2017","unstructured":"Murphy P, Moline M, Mayleben D, Rosenberg R, Zammit G, Pinner K, et al. Lemborexant, a dual orexin receptor antagonist (DORA) for the treatment of insomnia disorder: results from a Bayesian, adaptive, randomized, double-blind, placebo-controlled study. J Clin Sleep Med. 2017;13(11):1289\u201399. https:\/\/doi.org\/10.5664\/jcsm.6800.","journal-title":"J Clin Sleep Med"},{"key":"948_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.sleep.2022.01.024","volume":"90","author":"T Roth","year":"2022","unstructured":"Roth T, Rosenberg R, Morin CM, Yardley J, Pinner K, Perdomo C, et al. Impact of lemborexant treatment on insomnia severity: analyses from a 12-month study of adults with insomnia disorder. Sleep Med. 2022;90:249\u201357. https:\/\/doi.org\/10.1016\/j.sleep.2022.01.024.","journal-title":"Sleep Med"},{"issue":"1","key":"948_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ana.26641","volume":"94","author":"BP Lucey","year":"2023","unstructured":"Lucey BP, Liu H, Toedebusch CD, Freund D, Redrick T, Chahin SL, et al. Suvorexant acutely decreases tau phosphorylation and A\u03b2 in the human CNS. Ann Neurol. 2023;94(1):27\u201340. https:\/\/doi.org\/10.1002\/ana.26641.","journal-title":"Ann Neurol"},{"issue":"2","key":"948_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1124\/jpet.117.241422","volume":"362","author":"CT Beuckmann","year":"2017","unstructured":"Beuckmann CT, Suzuki M, Ueno T, Nagaoka K, Arai T, Higashiyama H. In vitro and in silico characterization of lemborexant (E2006), a novel dual orexin receptor antagonist. J Pharmacol Exp Ther. 2017;362(2):287\u201395. https:\/\/doi.org\/10.1124\/jpet.117.241422.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"948_CR20","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0896-6273(00)80974-5","volume":"19","author":"DR Borchelt","year":"1997","unstructured":"Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, et al. Accelerated amyloid deposition in the brains of Transgenic mice Coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 1997;19(4):939\u201345. https:\/\/doi.org\/10.1016\/S0896-6273(00)80974-5. PubMed PMID: 9354339.","journal-title":"Neuron"},{"issue":"11","key":"948_CR21","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/sleep\/30.11.1555","volume":"30","author":"T Roth","year":"2007","unstructured":"Roth T, Rogowski R, Hull S, Schwartz H, Koshorek G, Corser B, et al. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia. Sleep. 2007;30(11):1555\u201361. https:\/\/doi.org\/10.1093\/sleep\/30.11.1555.","journal-title":"Sleep"},{"issue":"8","key":"948_CR22","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.5665\/sleep.3936","volume":"37","author":"GM Mang","year":"2014","unstructured":"Mang GM, Nicod J, Emmenegger Y, Donohue KD, O\u2019Hara BF, Franken P. Evaluation of a piezoelectric system as an alternative to electroencephalogram\/electromyogram recordings in mouse sleep studies. Sleep. 2014;37(8):1383\u201392. https:\/\/doi.org\/10.5665\/sleep.3936.","journal-title":"Sleep"},{"issue":"259","key":"948_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jneumeth.2015.11.004","volume":"259","author":"F Yaghouby","year":"2016","unstructured":"Yaghouby F, Donohue KD, O\u2019Hara BF, Sunderam S. Noninvasive dissection of mouse sleep using a piezoelectric motion sensor. J Neurosci Methods. 2016;259(259):90\u2013100. https:\/\/doi.org\/10.1016\/j.jneumeth.2015.11.004.","journal-title":"J Neurosci Methods"},{"key":"948_CR24","doi-asserted-by":"publisher","unstructured":"Constantino NJ, Carroll CM, Williams HC, Vekaria HJ, Yuede CM, Saito K, et al. ATP-sensitive potassium channels alter glycolytic flux to modulate cortical activity and sleep. Proc Natl Acad Sci USA. 2025;122(8):e2416578122. https:\/\/doi.org\/10.1073\/pnas.2416578122.","DOI":"10.1073\/pnas.2416578122"},{"issue":"1","key":"948_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s44400-025-00054-8","volume":"2","author":"RE Irmen","year":"2026","unstructured":"Irmen RE, Turner SM, Snipes JA, Schloss KH, Wang X, Williams HC, et al. Tau pathology reprograms glucose metabolism to support cortical hyperexcitability, excitatory\/inhibitory imbalance, and sleep loss. npj Dement. 2026;2(1):6. https:\/\/doi.org\/10.1038\/s44400-025-00054-8.","journal-title":"npj Dement"},{"issue":"3","key":"948_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.nbd.2010.06.018","volume":"40","author":"KE Schwetye","year":"2010","unstructured":"Schwetye KE, Cirrito JR, Esparza TJ, Mac Donald CL, Holtzman DM, Brody DL. Traumatic brain injury reduces soluble extracellular amyloid-\u03b2 in mice: a methodologically novel combined microdialysis-controlled cortical impact study. Neurobiol Disease. 2010;40(3):555\u201364. https:\/\/doi.org\/10.1016\/j.nbd.2010.06.018.","journal-title":"Neurobiol Disease"},{"issue":"1","key":"948_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","volume":"50","author":"TR Hammond","year":"2019","unstructured":"Hammond TR, Dufort C, Dissing-Olesen L, Giera S, Young A, Wysoker A, et al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity. 2019;50(1):253\u201371.e6. https:\/\/doi.org\/10.1016\/j.immuni.2018.11.004. PubMed PMID: 30471926.","journal-title":"Immunity"},{"issue":"1","key":"948_CR28","doi-asserted-by":"publisher","first-page":"100265","DOI":"10.1016\/j.xpro.2020.100265","volume":"2","author":"SF Lau","year":"2021","unstructured":"Lau SF, Wu W, Seo H, Fu AKY, Ip NY. Quantitative in vivo assessment of amyloid-beta phagocytic capacity in an Alzheimer\u2019s disease mouse model. Star Protoc. 2021;2(1):100265. https:\/\/doi.org\/10.1016\/j.xpro.2020.100265.","journal-title":"Star Protoc"},{"issue":"22","key":"948_CR29","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","volume":"185","author":"S Wang","year":"2022","unstructured":"Wang S, Sudan R, Peng V, Zhou Y, Du S, Yuede CM, et al. TREM2 drives microglia response to amyloid-\u03b2 via SYK-dependent and -independent pathways. Cell. 2022;185(22):4153\u201369.e19. https:\/\/doi.org\/10.1016\/j.cell.2022.09.033.","journal-title":"Cell"},{"issue":"1","key":"948_CR30","doi-asserted-by":"publisher","first-page":"14049","DOI":"10.1038\/ncomms14049","volume":"8","author":"GXY Zheng","year":"2017","unstructured":"Zheng GXY, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R, et al. Massively parallel digital transcriptional profiling of single cells. Nat Commun. 2017;8(1):14049. https:\/\/doi.org\/10.1038\/ncomms14049.","journal-title":"Nat Commun"},{"key":"948_CR31","doi-asserted-by":"publisher","unstructured":"Young MD, Behjati S. SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data. GigaScience. 2020;9(12):giaa151. https:\/\/doi.org\/10.1093\/gigascience\/giaa151.","DOI":"10.1093\/gigascience\/giaa151"},{"issue":"2","key":"948_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2024;42(2):293\u2013304. https:\/\/doi.org\/10.1038\/s41587-023-01767-y.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"948_CR33","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s41593-019-0393-4","volume":"22","author":"H Van Hove","year":"2019","unstructured":"Van Hove H, Martens L, Scheyltjens I, De Vlaminck K, Pombo Antunes AR, De Prijck S, et al. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nat Neurosci. 2019;22(6):1021\u201335. https:\/\/doi.org\/10.1038\/s41593-019-0393-4.","journal-title":"Nat. Neurosci"},{"key":"948_CR34","doi-asserted-by":"publisher","unstructured":"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, et al. Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J Exp Med. 2020;217(9):e20200785. https:\/\/doi.org\/10.1084\/jem.20200785.","DOI":"10.1084\/jem.20200785"},{"issue":"1","key":"948_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"948_CR36","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28(11):1947\u201351. https:\/\/doi.org\/10.1002\/pro.3715.","journal-title":"Protein Sci"},{"key":"948_CR37","doi-asserted-by":"publisher","unstructured":"Kanehisa M, Furumichi M, Sato Y, Matsuura Y, Ishiguro-Watanabe M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 2025;53(D1):D672\u20137. https:\/\/doi.org\/10.1093\/nar\/gkae909.","DOI":"10.1093\/nar\/gkae909"},{"issue":"5","key":"948_CR38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics J Intgr Biol. 2012;16(5):284\u201387. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"Omics: J Intgr Biol"},{"key":"948_CR39","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pbb.2014.12.002","volume":"129","author":"YQ Wang","year":"2015","unstructured":"Wang YQ, Takata Y, Li R, Zhang Z, Zhang MQ, Urade Y, et al. Doxepin and diphenhydramine increased non-rapid eye movement sleep through blockade of histamine H1 receptors. Pharmacol Biochem Behav. 2015;129:56\u201364. https:\/\/doi.org\/10.1016\/j.pbb.2014.12.002.","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"948_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0002-9440(10)63945-4","volume":"158","author":"KD Bornemann","year":"2001","unstructured":"Bornemann KD, Wiederhold KH, Pauli C, Ermini F, Stalder M, Schnell L, et al. A\u03b2-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am J Pathol. 2001;158(1):63\u201373. https:\/\/doi.org\/10.1016\/S0002-9440(10)63945-4. PubMed PMID: 11141480.","journal-title":"Am J Pathol"},{"issue":"4","key":"948_CR41","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","volume":"74","author":"DP Schafer","year":"2012","unstructured":"Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74(4):691\u2013705. https:\/\/doi.org\/10.1016\/j.neuron.2012.03.026. PubMed PMID: 22632727.","journal-title":"Neuron"},{"issue":"4","key":"948_CR42","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/glia.22295","volume":"60","author":"W Kamphuis","year":"2012","unstructured":"Kamphuis W, Orre M, Kooijman L, Dahmen M, Hol EM. Differential cell proliferation in the cortex of the appsweps1de9 alzheimer\u2019s disease mouse model. Glia. 2012;60(4):615\u201329. https:\/\/doi.org\/10.1002\/glia.22295.","journal-title":"Glia"},{"issue":"6","key":"948_CR43","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell. 2015;160(6):1061\u201371. https:\/\/doi.org\/10.1016\/j.cell.2015.01.049. PubMed PMID: 25728668.","journal-title":"Cell"},{"issue":"7","key":"948_CR44","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169(7):1276\u201390.e17. https:\/\/doi.org\/10.1016\/j.cell.2017.05.018. PubMed PMID: 28602351.","journal-title":"Cell"},{"issue":"3","key":"948_CR45","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47(3):566\u201381.e9. https:\/\/doi.org\/10.1016\/j.immuni.2017.08.008.","journal-title":"Immunity"},{"issue":"22","key":"948_CR46","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.15252\/embj.201696056","volume":"36","author":"A Wlodarczyk","year":"2017","unstructured":"Wlodarczyk A, Holtman IR, Krueger M, Yogev N, Bruttger J, Khorooshi R, et al. A novel microglial subset plays a key role in myelinogenesis in developing brain. Embo J. 2017;36(22):3292\u2013308. https:\/\/doi.org\/10.15252\/embj.201696056.","journal-title":"Embo J"},{"issue":"5","key":"948_CR47","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/glia.24674","volume":"73","author":"N Ghena","year":"2025","unstructured":"Ghena N, Anderson SR, Roberts JM, Irvin E, Schwakopf J, Bosco A, et al. CD11c-expressing microglia are transient, driven by interactions with apoptotic cells. Glia. 2025;73(5):1077\u201389. https:\/\/doi.org\/10.1002\/glia.24674.","journal-title":"Glia"},{"issue":"8","key":"948_CR48","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41593-018-0192-3","volume":"21","author":"P Ayata","year":"2018","unstructured":"Ayata P, Badimon A, Strasburger HJ, Duff MK, Montgomery SE, Loh YHE, et al. Epigenetic regulation of brain region-specific microglia clearance activity. Nat Neurosci. 2018;21(8):1049\u201360. https:\/\/doi.org\/10.1038\/s41593-018-0192-3.","journal-title":"Nat. Neurosci"},{"issue":"2","key":"948_CR49","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neuron.2014.02.040","volume":"82","author":"MRP Elmore","year":"2014","unstructured":"Elmore MRP, Najafi AR, Koike MA, Dagher NN, Spangenberg EE, Rice RA, et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron. 2014;82(2):380\u201397. https:\/\/doi.org\/10.1016\/j.neuron.2014.02.040. PubMed PMID: 24742461.","journal-title":"Neuron"},{"issue":"9","key":"948_CR50","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.it.2020.07.001","volume":"41","author":"KN Green","year":"2020","unstructured":"Green KN, Crapser JD, Hohsfield LA. To kill a microglia: a case for CSF1R inhibitors. Trends Immunol. 2020;41(9):771\u201384. https:\/\/doi.org\/10.1016\/j.it.2020.07.001. PubMed PMID: 32792173.","journal-title":"Trends Immunol"},{"issue":"1","key":"948_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-11674-z","volume":"10","author":"E Spangenberg","year":"2019","unstructured":"Spangenberg E, Severson PL, Hohsfield LA, Crapser J, Zhang J, Burton EA, et al. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer\u2019s disease model. Nat Commun. 2019;10(1):1. https:\/\/doi.org\/10.1038\/s41467-019-11674-z.","journal-title":"Nat Commun"},{"issue":"1","key":"948_CR52","doi-asserted-by":"publisher","first-page":"10634","DOI":"10.1038\/s41467-024-54779-w","volume":"15","author":"N Balig\u00e1cs","year":"2024","unstructured":"Balig\u00e1cs N, Albertini G, Borrie SC, Serneels L, Pridans C, Balusu S, et al. Homeostatic microglia initially seed and activated microglia later reshape amyloid plaques in Alzheimer\u2019s disease. Nat Commun. 2024;15(1):10634. https:\/\/doi.org\/10.1038\/s41467-024-54779-w.","journal-title":"Nat Commun"},{"issue":"7","key":"948_CR53","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.celrep.2019.04.062","volume":"27","author":"SR Anderson","year":"2019","unstructured":"Anderson SR, Roberts JM, Zhang J, Steele MR, Romero CO, Bosco A, et al. Developmental apoptosis promotes a disease-related gene signature and independence from CSF1R signaling in retinal microglia. Cell Rep. 2019;27(7):2002\u201313.e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.04.062. PubMed PMID: 31091440.","journal-title":"Cell Rep"},{"key":"948_CR54","doi-asserted-by":"publisher","unstructured":"Anderson SR, Roberts JM, Ghena N, Irvin EA, Schwakopf J, Cooperstein IB, et al. Neuronal apoptosis drives remodeling states of microglia and shifts in survival pathway dependence. Garel S, Bronner ME, editors. eLife. 2022;11:e76564. https:\/\/doi.org\/10.7554\/eLife.76564.","DOI":"10.7554\/eLife.76564"},{"issue":"8","key":"948_CR55","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1056\/NEJMoa2310168","volume":"390","author":"J Jia","year":"2024","unstructured":"Jia J, Ning Y, Chen M, Wang S, Yang H, Li F, et al. Biomarker changes during 20 years preceding Alzheimer\u2019s disease. N Engl J Med. 2024;390(8):712\u201322. https:\/\/doi.org\/10.1056\/NEJMoa2310168.","journal-title":"N Engl J Med"},{"issue":"5","key":"948_CR56","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/ana.26891","volume":"95","author":"Y Li","year":"2024","unstructured":"Li Y, Yen D, Hendrix RD, Gordon BA, Dlamini S, Barth\u00e9lemy NR, et al. Timing of Biomarker changes in sporadic Alzheimer\u2019s disease in estimated years from symptom onset. Ann Neurol. 2024;95(5):951\u201365. https:\/\/doi.org\/10.1002\/ana.26891.","journal-title":"Ann Neurol"},{"issue":"9","key":"948_CR57","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC, et al. Clinical and Biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med. 2012;367(9):795\u2013804. https:\/\/doi.org\/10.1056\/NEJMoa1202753.","journal-title":"N Engl J Med"},{"key":"948_CR58","doi-asserted-by":"publisher","unstructured":"Schindler SE, Li Y, Buckles VD, Gordon BA, Benzinger TLS, Wang G, et al. Predicting symptom onset in sporadic Alzheimer disease with amyloid PET. Neurology. 2021;97(18):e1823\u201334. https:\/\/doi.org\/10.1212\/WNL.0000000000012775.","DOI":"10.1212\/WNL.0000000000012775"},{"issue":"1","key":"948_CR59","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH Van Dyck","year":"2023","unstructured":"Van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948.","journal-title":"N Engl J Med"},{"issue":"4","key":"948_CR60","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S1474-4422(25)00024-9","volume":"24","author":"RJ Bateman","year":"2025","unstructured":"Bateman RJ, Li Y, McDade EM, Llibre-Guerra JJ, Clifford DB, Atri A, et al. Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer\u2019s disease: an open-label extension of the phase 2\/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial. Lancet Neurol. 2025;24(4):316\u201330. https:\/\/doi.org\/10.1016\/S1474-4422(25)00024-9. PubMed PMID: 40120616.","journal-title":"The Lancet Neurol"},{"issue":"6315","key":"948_CR61","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1126\/science.aah4968","volume":"354","author":"ES Musiek","year":"2016","unstructured":"Musiek ES, Holtzman DM. Mechanisms linking circadian clocks, sleep, and neurodegeneration. Science. 2016;354(6315):1004\u201308. https:\/\/doi.org\/10.1126\/science.aah4968.","journal-title":"Science"},{"issue":"17","key":"948_CR62","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1073\/pnas.1721694115","volume":"115","author":"E Shokri-Kojori","year":"2018","unstructured":"Shokri-Kojori E, Wang GJ, Wiers CE, Demiral SB, Guo M, Kim SW, et al. \u03b2-amyloid accumulation in the human brain after one night of sleep deprivation. Proc Natl Acad Sci USA. 2018;115(17):4483\u201388. https:\/\/doi.org\/10.1073\/pnas.1721694115.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"948_CR63","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/brain\/awaa443","volume":"144","author":"PK Eide","year":"2021","unstructured":"Eide PK, Vinje V, Pripp AH, Mardal KA, Ringstad G. Sleep deprivation impairs molecular clearance from the human brain. Brain. 2021;144(3):863\u201374. https:\/\/doi.org\/10.1093\/brain\/awaa443.","journal-title":"Brain"},{"issue":"8","key":"948_CR64","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1001\/jamaneurol.2014.1173","volume":"71","author":"S Ooms","year":"2014","unstructured":"Ooms S, Overeem S, Besse K, Rikkert MO, Verbeek M, Claassen JAHR. Effect of 1 night of total sleep deprivation on cerebrospinal fluid \u03b2-amyloid 42 in healthy middle-aged men: a randomized clinical trial. JAMA Neurol. 2014;71(8):971\u201377. https:\/\/doi.org\/10.1001\/jamaneurol.2014.1173.","journal-title":"JAMA Neurol"},{"issue":"8","key":"948_CR65","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1093\/brain\/awx148","volume":"140","author":"YES Ju","year":"2017","unstructured":"Ju YES, Ooms SJ, Sutphen C, Macauley SL, Zangrilli MA, Jerome G, et al. Slow wave sleep disruption increases cerebrospinal fluid amyloid-\u03b2 levels. Brain. 2017;140(8):2104\u201311. https:\/\/doi.org\/10.1093\/brain\/awx148.","journal-title":"Brain"},{"issue":"9","key":"948_CR66","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1001\/jamaneurol.2022.1732","volume":"79","author":"ES Musiek","year":"2022","unstructured":"Musiek ES, Ju YES. Targeting sleep and circadian function in the prevention of Alzheimer disease. JAMA Neurol. 2022;79(9):835\u201336. https:\/\/doi.org\/10.1001\/jamaneurol.2022.1732.","journal-title":"JAMA Neurol"},{"issue":"7058","key":"948_CR67","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nature04071","volume":"437","author":"GC Harris","year":"2005","unstructured":"Harris GC, Wimmer M, Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature. 2005;437(7058):556\u201359. https:\/\/doi.org\/10.1038\/nature04071.","journal-title":"Nature"},{"issue":"52","key":"948_CR68","doi-asserted-by":"publisher","first-page":"19168","DOI":"10.1073\/pnas.0507480102","volume":"102","author":"B Boutrel","year":"2005","unstructured":"Boutrel B, Kenny PJ, Specio SE, Martin-Fardon R, Markou A, Koob GF, et al. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci USA. 2005;102(52):19168\u201373. https:\/\/doi.org\/10.1073\/pnas.0507480102.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"948_CR69","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","volume":"98","author":"RM Chemelli","year":"1999","unstructured":"Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 1999;98(4):437\u201351. https:\/\/doi.org\/10.1016\/S0092-8674(00)81973-X.","journal-title":"Cell"},{"issue":"2","key":"948_CR70","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1124\/pr.109.001321","volume":"61","author":"N Tsujino","year":"2009","unstructured":"Tsujino N, Sakurai T. Orexin\/hypocretin: a Neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev. 2009;61(2):162\u201376. https:\/\/doi.org\/10.1124\/pr.109.001321.","journal-title":"Pharmacol Rev"},{"key":"948_CR71","doi-asserted-by":"publisher","unstructured":"Roh JH, Huang Y, Bero AW, Kasten T, Stewart FR, Bateman RJ, et al. Disruption of the sleep-wake cycle and diurnal fluctuation of \u03b2-amyloid in mice with Alzheimer\u2019s disease pathology. Sci Transl Med. 2012;4(150). https:\/\/doi.org\/10.1126\/scitranslmed.3004291.","DOI":"10.1126\/scitranslmed.3004291"},{"issue":"7","key":"948_CR72","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/s41593-025-01966-7","volume":"28","author":"S Parhizkar","year":"2025","unstructured":"Parhizkar S, Bao X, Chen W, Rensing N, Chen Y, Kipnis M, et al. Lemborexant ameliorates tau-mediated sleep loss and neurodegeneration in males in a mouse model of tauopathy. Nat. Neurosci. 2025;1\u201313;28(7):1460\u201372. https:\/\/doi.org\/10.1038\/s41593-025-01966-7.","journal-title":"Nat. Neurosci"},{"issue":"1","key":"948_CR73","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.trci.2019.01.003","volume":"5","author":"MJ Duncan","year":"2019","unstructured":"Duncan MJ, Farlow H, Tirumalaraju C, Yun DH, Wang C, Howard JA, et al. Effects of the dual orexin receptor antagonist DORA-22 on sleep in 5XFAD mice. Alzheimers Dement Transl Res Clin Interv. 2019;5(1):70\u201380. https:\/\/doi.org\/10.1016\/j.trci.2019.01.003.","journal-title":"A D Transl Res Clin Interv"},{"issue":"4","key":"948_CR74","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00401-013-1177-7","volume":"126","author":"PL McGeer","year":"2013","unstructured":"McGeer PL, McGeer EG. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol (Berl). 2013;126(4):479\u201397. https:\/\/doi.org\/10.1007\/s00401-013-1177-7.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"6","key":"948_CR75","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med. 2016;8(6):595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210.","journal-title":"EMBO Mol Med"},{"key":"948_CR76","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.arr.2016.07.002","volume":"32","author":"S Sol\u00e9-Dom\u00e8nech","year":"2016","unstructured":"Sol\u00e9-Dom\u00e8nech S, Cruz DL, Capetillo-Zarate E, Maxfield FR. The endocytic pathway in microglia during health, aging and Alzheimer\u2019s disease. Ageing Res Rev. 2016;32:89\u2013103. https:\/\/doi.org\/10.1016\/j.arr.2016.07.002.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"948_CR77","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/glia.440070114","volume":"7","author":"PL McGeer","year":"1993","unstructured":"McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG. Microglia in degenerative neurological disease. Glia. 1993;7(1):84\u201392. https:\/\/doi.org\/10.1002\/glia.440070114.","journal-title":"Glia"},{"issue":"9","key":"948_CR78","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus H, Heneka MT. Microglia in Alzheimer\u2019s disease. J Clin Invest. 2017;127(9):3240\u201349. https:\/\/doi.org\/10.1172\/JCI90606.","journal-title":"J Clin Investigation"},{"issue":"10","key":"948_CR79","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","volume":"19","author":"O Butovsky","year":"2018","unstructured":"Butovsky O, Weiner HL. Microglial signatures and their role in health and disease. Nat Rev Neurosci. 2018;19(10):622\u201335. https:\/\/doi.org\/10.1038\/s41583-018-0057-5.","journal-title":"Nat. Rev. Neurosci"},{"issue":"5","key":"948_CR80","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","volume":"173","author":"A Deczkowska","year":"2018","unstructured":"Deczkowska A, Keren-Shaul H, Weiner A, Colonna M, Schwartz M, Amit I. Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell. 2018;173(5):1073\u201381. https:\/\/doi.org\/10.1016\/j.cell.2018.05.003.","journal-title":"Cell"},{"issue":"3","key":"948_CR81","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17(3):157\u201372. https:\/\/doi.org\/10.1038\/s41582-020-00435-y.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"948_CR82","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13024-023-00682-9","volume":"18","author":"Q Zhao","year":"2023","unstructured":"Zhao Q, Maci M, Miller MR, Zhou H, Zhang F, Algamal M, et al. Sleep restoration by optogenetic targeting of GABAergic neurons reprograms microglia and ameliorates pathological phenotypes in an Alzheimer\u2019s disease model. Mol Neurodegener. 2023;18(1):93. https:\/\/doi.org\/10.1186\/s13024-023-00682-9.","journal-title":"Mol Neurodegener"},{"key":"948_CR83","doi-asserted-by":"publisher","unstructured":"Chen Y, Colonna M. Microglia in Alzheimer\u2019s disease at single-cell level. Are there common patterns in humans and mice? J Exp Med. 2021;218(9):e20202717. https:\/\/doi.org\/10.1084\/jem.20202717.","DOI":"10.1084\/jem.20202717"},{"key":"948_CR84","doi-asserted-by":"publisher","unstructured":"Moutinho M, Puntambekar SS, Tsai AP, Coronel I, Lin PB, Casali BT, et al. The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer\u2019s disease. Sci Transl Med. 2022;14(637):eabl7634. https:\/\/doi.org\/10.1126\/scitranslmed.abl7634.","DOI":"10.1126\/scitranslmed.abl7634"},{"issue":"120","key":"948_CR85","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.bbi.2024.07.002","volume":"120","author":"MR Duggan","year":"2024","unstructured":"Duggan MR, Gomez GT, Joynes CM, Bilgel M, Chen J, Fattorelli N, et al. Proteome-wide analysis identifies plasma immune regulators of amyloid-beta progression. Brain Behav Immun. 2024;120(120):604\u201319. https:\/\/doi.org\/10.1016\/j.bbi.2024.07.002.","journal-title":"Brain Behav Immun"},{"issue":"7953","key":"948_CR86","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","volume":"615","author":"X Chen","year":"2023","unstructured":"Chen X, Firulyova M, Manis M, Herz J, Smirnov I, Aladyeva E, et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature. 2023;615(7953):668\u201377. https:\/\/doi.org\/10.1038\/s41586-023-05788-0.","journal-title":"Nature"},{"issue":"3","key":"948_CR87","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/STROKEAHA.112.681700","volume":"44","author":"X Xiong","year":"2013","unstructured":"Xiong X, White RE, Xu L, Yang L, Sun X, Zou B, et al. Mitigation of murine focal cerebral ischemia by the Hypocretin\/Orexin System is associated with reduced inflammation. Stroke. 2013;44(3):764\u201370. https:\/\/doi.org\/10.1161\/STROKEAHA.112.681700.","journal-title":"Stroke"},{"issue":"1","key":"948_CR88","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3233\/JAD-170108","volume":"58","author":"H An","year":"2017","unstructured":"An H, Cho MH, Kim DH, Chung S, Yoon SY. Orexin impairs the phagocytosis and degradation of amyloid-\u03b2 fibrils by microglial cells. J Alzheimers Dis. 2017;58(1):253\u201361. https:\/\/doi.org\/10.3233\/JAD-170108.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"948_CR89","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/00325481.2020.1823724","volume":"133","author":"M Moline","year":"2021","unstructured":"Moline M, Zammit G, Yardley J, Pinner K, Kumar D, Perdomo C, et al. Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials. Postgrad Med. 2021;133(1):71\u201381. https:\/\/doi.org\/10.1080\/00325481.2020.1823724. PubMed PMID: 33119423.","journal-title":"Postgrad Med"},{"issue":"31","key":"948_CR90","doi-asserted-by":"publisher","first-page":"11784","DOI":"10.1073\/pnas.0604681103","volume":"103","author":"O Butovsky","year":"2006","unstructured":"Butovsky O, Koronyo-Hamaoui M, Kunis G, Ophir E, Landa G, Cohen H, et al. Glatiramer acetate fights against Alzheimer\u2019s disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc Natl Acad Sci USA. 2006;103(31):11784\u201389. https:\/\/doi.org\/10.1073\/pnas.0604681103.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00948-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00948-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00948-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T21:50:27Z","timestamp":1779832227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13024-026-00948-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["948"],"URL":"https:\/\/doi.org\/10.1186\/s13024-026-00948-y","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Several authors are employees of Eisai Pharmaceuticals, the maker of lemobrexant. The study was carried out at Washington University but was funded by a sponsored research agreement between Eisai and Washington University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}